Erchonia Receives FDA Market Clearance for New Z-6 Laser

Share Article

Upgrade Improves Upon Zerona Technology for Safe, Effective, Non-Invasive Body Contouring

Erchonia Z-6

The Z-6 showcases significant improvements to the Zerona system providing an overall better treatment for the patient.

Erchonia today announces the U.S. Food and Drug Administration (FDA) has granted the company 510 (k) clearance to market its new Z-6 low level laser for the safe and effective non-invasive circumferential reduction of the waist, hips and thighs. The Z-6 laser is a newly-upgraded version of Erchonia’s popular Zerona laser featuring an additional laser head for a total of six lasers to enhance coverage, maximize efficiency and improve ease of use.

“After five years on the market, Erchonia is excited to update our Zerona technology with the Z-6,” says Charlie Shanks, vice president of Erchonia. “The Z-6 showcases significant improvements to the Zerona system providing an overall better treatment for the patient. To usher in the new technology, Erchonia is offering a trade in opportunity for existing Zerona customers to upgrade to the Z-6.”

Like the Zerona, the Z-6 also emits neither heat nor cold—in fact, you can’t even feel it. The laser system creates a pore in fat cells, fat leaks out and the fat is then processed by the body as waste. The cell is not destroyed and can still secrete beneficial hormones. In a double-blind, placebo-controlled, multi-site clinical trial, patients treated with the laser lost an average of 3.5 inches from their waists, hips and thighs without any dietary changes, exercise requirements or supplements.

The FDA has previously cleared Erchonia’s low level lasers for non-invasive reduction of cellulite, the non-invasive circumference reduction of the arms; for liposuction and breast augmentation assistance and the reduction of associated pain; the reduction of chronic neck and shoulder pain; and for the treatment of acne.

For more information, please visit

About Erchonia
Erchonia is the global leader in low level laser healthcare applications. Over the last 15 years Erchonia has been conducting research and development with the world’s leading physicians to advance the science of low level lasers. Prior to market introduction, all Erchonia lasers are proven safe and effective through independent clinical trials. Currently thousands of Erchonia’s lasers are used daily to reduce body fat and cellulite, eliminate pain, and treat acne. For additional information, visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Katie Cycan
Visit website